Drugs / AdVEGF-All6A+
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01757223 | Dec 2020 → Oct 2030 | coronary artery disorder | Weill Medical College of Cornell University | Withdrawn | No outcome recorded Stop: Business |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AdVEGF-All6A+ | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01757223 ↗ |
| Route | Other | “injection under direct vision during a minimally invasive thoracic surgery” NCT01757223 ↗ |